Innate Versus Adaptive Immunity in Candida Albicans Infection by Ashman, Robert B. et al.
Immunology and Cell Biology
 
 (2004) 
 
82
 
, 196–204 doi:10.1046/j.0818-9641.2004.01217.x
© 2004 Australasian Society for Immunology Inc.
 
Special Feature
 
Innate versus adaptive immunity in 
 
Candida albicans
 
 infection
 
R O B E R T  B  A S H M A N ,  C A M I L E  S  F A R A H ,  S I R I P E N  W A N A S A E N G S A K U L ,  
Y A N  H U ,  G E R A L D  P A N G  a n d  R O B E R T  L  C L A N C Y
 
School of Dentistry, University of Queensland, Brisbane, Queensland, and School of Biomedical Sciences, University of 
Newcastle, Newcastle, NSW, Australia
 
Summary  
 
Candida albicans
 
 is a common opportunistic pathogen, causing both superficial and systemic infection.
Clinical observations indicate that mucocutaneous infections are commonly associated with defective cell-mediated
immune responses, whereas systemic infection is more frequently seen in patients with deficiencies in neutrophil
number or function. Analysis of mechanisms of host resistance against gastrointestinal and oral infection in mouse
models has demonstrated an absolute dependence on CD4
 
+
 
 T cells, although clearance also involves phagocytic
cells. Both IL-12 and TNF-
 
α
 
 appear to be important mediators, but mouse strain-dependent variations in
susceptibility to infection may be related to T-cell enhancement of production of phagocytic cells by the bone
marrow. In murine systemic infection, the role of innate and adaptive responses is less well defined. Studies in
immunodeficient and T-cell-depleted mice suggest that clearance of the yeast may be predominantly a function of
the innate response, whereas the adaptive response may either limit tissue damage or have the potential to cause
immunopathology, depending on the host genetic context in which the infection takes place.
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Introduction
 
The yeast 
 
Candida albicans
 
 is a widespread opportunistic
pathogen. Mucocutaneous infections, that manifest as either
oral or vaginal ‘thrush’, are commonly encountered in
medical and dental practice; and the incidence of systemic
candidiasis has risen dramatically over the past decades in
parallel with the increasing sophistication of medical technol-
ogy and widespread use of aggressive therapeutic regimens
for transplantation and cancer patients.
Despite the prevalence of 
 
Candida
 
 in the hospital environ-
ment – it is now the fourth most common nosocomial
infection
 
1
 
 – the pathways involved in clearance of mucocuta-
neous and systemic infections with the organism have not
been fully delineated. Patients with congenital or acquired
defects in cell-mediated immunity are particularly susceptible
to mucocutaneous, but not to disseminated candidiasis
 
2
 
whereas systemic infections are more commonly associated
with neutropenia
 
3
 
 or congenital defects that affect neutrophil
function.
 
4
 
 Although disseminated candidiasis can often origi-
nate from the gastrointestinal tract,
 
5
 
 it is unclear whether the
mechanism(s) that mediate host resistance against the differ-
ent manifestations of the disease are similar, or significantly
different.
 
Models of infection
 
In inbred mice, both systemic
 
6
 
 and oral
 
7
 
 candidiasis closely
resemble the human disease. Both neutrophils and macrophages
have been shown to exert candidacidal activity, and probably
represent the first line of defence against 
 
Candida
 
 infection,
but studies of animal models have demonstrated that T cells
are essential for recovery from oropharyngeal candidiasis,
and cell-mediated immunity has also been implicated in the
development of 
 
Candida
 
-specific protection in murine sys-
temic candidiasis. Activation of phagocytes by T-cell-mediated
cytokines appears to be necessary for the full expression of
resistance against the disease,
 
8
 
 and a bias towards a T-helper
type 1 (Th1) or type 2 (Th2) cytokine profile after systemic
infection with either an avirulent or a virulent strain of the
yeast has been linked to the induction of protection, or
development of chronic disease, in different mouse strains.
 
9
 
Nevertheless, the applicability of this paradigm to other
models of the infection has been questioned.
 
10
 
 There is no
increase in the severity or duration of disease after systemic
infection of immunodeficient nude
 
11,12
 
 or SCID
 
13
 
 mice, which
argues against an essential role for T cells in clearance of the
yeast, although depletion studies
 
14
 
 have indicated that both
CD4
 
+
 
 and CD8
 
+
 
 lymphocytes may play a part in limiting the
extent of tissue lesions. In addition, analysis of cytokines in
lesions of mice that are genetically predisposed to develop
either severe or mild tissue pathology has failed to demon-
strate any correlation between the extent of tissue destruction
and a Th1 or Th2 cytokine profile.
 
15
 
In this paper, models of oro-pharyngeal and systemic
candidiasis are described, and the relative importance of
innate and adaptive immune responses in each are evaluated.
 
Mucocutaneous candidiasis
 
In humans, 
 
Candida
 
 species are frequently isolated from
various mucosal sites within the oral cavity, oesophagus, and
gastrointestinal (GI) tract, but few healthy carriers develop
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clinical signs of disease. It is typically alterations in the
integrity of the immune system that ultimately determine
whether the fungus remains as a simple commensal, or
proliferates and causes disease.
Early studies of children with chronic mucocutaneous
candidiasis
 
16
 
 demonstrated a strong association with defects
in cell-mediated immunity, and the importance of T cells,
(and particularly CD4
 
+
 
 cells) in the host response has been
reinforced by the high incidence of oropharyngeal candidiasis
in patients with HIV-infection with reduced CD4
 
+
 
 cell
counts.
 
17
 
 Salivary cytokine analysis in HIV-negative individ-
uals showed a Th0/Th1 profile, whereas HIV-infected
persons with oropharyngeal candidiasis demonstrated pre-
dominantly Th2-type cytokines.
 
18
 
 Salivary cytokine profiles
in HIV-negative denture wearers either with or without denture
stomatitis demonstrated a mixed Th1/Th2 profile.
 
19
 
Mohamed
 
20
 
 noted the presence of 
 
C. albicans
 
 inside
macrophages in the oral mucosa of humans, suggesting that
these cells play a role in resistance to mucosal candidiasis – a
conclusion consistent with the reduced capacity of HIV
infected monocyte-derived macrophages to phagocytose the
yeast.
 
21
 
 Patients with 
 
Candida
 
-associated denture stomatitis
also show evidence of an impaired cellular immune response
of blood lymphocytes against antigens from 
 
C. albicans in
vivo
 
 (skin test) and 
 
in vitro
 
 (leucocyte migration test)
 
22
 
 and
may have overactive suppressor T cells or other lymphocyte/
phagocyte defects
 
23
 
 indicating that normal immunoregula-
tory responses can also be impaired in patients with oral
candidiasis.
 
Mouse models
 
Understanding the mechanisms of recovery from mucosal
candidiasis has been complicated by a plethora of experimental
models, and by the extrapolation of results from infection of
one particular mucosal site (e.g. the gastrointestinal tract) to
other manifestations of the disease. Thus, despite intensive
investigation, there is little consensus about the host effector
pathways crucial for recovery from primary infection of the
oral mucosa.
 
Gastrointestinal candidiasis
 
Mucosal candidiasis of the gastrointestinal tract has been
studied in both immunodeficient and immunocompetent
mice. Both euthymic and athymic mice develop orogastric
candidiasis
 
24
 
 but only euthymic mice demonstrate 
 
Candida
 
-
specific lymphoproliferation and delayed-type hypersensitivity
(DTH) responses, that correlate with the clearance of
 
C. albicans
 
 hyphae from mucosal surfaces. These results
substantiated those of Domer
 
25
 
 who had earlier demonstrated
that gastrointestinal infection of immunologically immature
neonatal mice primed them for enhanced DTH responses, and
protected them from systemic challenge as adults. Treatment
of bg/bg nu/+ mice with anti-CD4 monoclonal antibody
depleted their CD4
 
+
 
 lymphocytes and increased their suscep-
tibility to 
 
Candida
 
 infection of the tongue and oesophagus.
 
26
 
This suggested that protection of mice from orogastric candi-
diasis was mediated by CD4
 
+
 
 lymphocytes, possibly via the
production of IFN-
 
γ
 
.
 
26
 
Further studies of host susceptibility to mucosal candidia-
sis have been carried out in SCID mice that lack functional T
and B cells, and in multiply immunodeficient (
 
bg
 
/
 
bg
 
, 
 
nu
 
/
 
n
 
µ
 
)
mice deficient in both T cells and phagocytic cells. After
intragastric or oral inoculation of 
 
C. albicans
 
, these mice
developed a persistent GI infection
 
24
 
 whereas mice that lacked
only phagocytic cells (
 
bg
 
/
 
bg, nu
 
/+) cleared the infection
efficiently.
 
27
 
 In contrast, B cell knockout mice, that lack both
functional B cells and antibodies, were as resistant to orogas-
tric candidiasis as immunocompetent controls.
 
28
 
 These data
are consistent with a primary role for cell-mediated immunity
in host protection against mucocutaneous candidiasis.
Numerous effector pathways of cell-mediated immunity
against mucosal candidiasis have been identified, but their
relative importance 
 
in vivo
 
 has not been established. A role
for CD4
 
+
 
 T-helper cytokines has been demonstrated in dis-
seminated candidiasis, and parallels have been found in
models of gastrointestinal infection. BALB/c mice are resis-
tant to systemic challenge with an avirulent isolate of
 
C. albicans
 
, and the generation of protective host responses is
associated with expression of a Th1 cytokine profile by CD4
 
+
 
T cells.
 
9
 
 In this mouse strain, systemic infection with a
virulent isolate caused early mortality, whereas gastrointesti-
nal colonization with the virulent yeast resulted in the produc-
tion of both Th1- and Th2-type cytokines by CD4
 
+
 
 cells from
Peyer’s patches and mesenteric lymph nodes, at a time when
the yeasts were being cleared from the intestine.
 
29
 
 In contrast,
DBA/2Cr mice develop fatal disseminated candidiasis after
intravenous infection with the avirulent strain of 
 
C. albicans
 
,
 
9
 
but intragastric inoculation with the virulent strain was again
associated with the induction of Th1-type cell-mediated
immune responses and eventual clearance of the infection.
 
30
 
IL-12-deficient mice were found to be highly susceptible to
primary gastrointestinal 
 
C. albicans
 
 infection or re-infection,
and showed elevated production of IL-4 with defective pro-
duction of IFN-
 
γ
 
,
 
31
 
 whereas administration of soluble IL-4
receptor (sIL-4R) to mice with gastrointestinal candidiasis
accelerated the clearance of the fungus from the stomach and
stimulated Th1-associated resistance.
 
32
 
 These data suggest
that activation of Th1- but not Th2-like responses may be
responsible for controlling orogastric candidiasis and generat-
ing protective immunity.
A role for T cells in defence against mucosal candidiasis
was further demonstrated by studies in multiply immunodefi-
cient mice. Mucosal 
 
C. albicans
 
 infection in the alimentary
tract of 
 
bg
 
/
 
bg nu
 
/
 
+
 
 mice induced a population of lymphocytes
in both the Peyer’s patches and spleen that proliferated and
produced IL-2 in response to stimulation with 
 
Candida
 
 anti-
gens.
 
26
 
 Depletion of CD4
 
+
 
 cells increased the susceptibility of
euthymic mice, but neither IL-2 nor IFN-
 
γ
 
 was essential for
the host response. 
 
Candida
 
-reactive lymphocytes were not
found in mice homozygous for the nude mutation (
 
bg
 
/
 
bg
nu
 
/
 
n
 
µ
 
), and these animals were unable to clear the yeasts.
The 
 
γ
 
/
 
δ
 
 T cells of the mucosa have also been implicated in the
process of host defence. Oral colonization with 
 
C. albicans
 
 in
B-cell-deficient mice, which have a normal T-cell response,
increased the number of both 
 
α
 
/
 
β
 
 and 
 
γ/δ
 
 T cells in the
gastrointestinal mucosa
 
33
 
 and intraperitoneal infection of
immunocompetent and knockout mice with 
 
C. albicans
 
resulted in an accumulation of 
 
γ
 
/
 
δ
 
 T cells in the peritoneal
cavity.
 
34
 
 The 
 
γ
 
/
 
δ
 
 T cells produced IFN-
 
γ
 
, that enhanced
 198
 
RB Ashmam 
 
et al
 
.
 
macrophage candidacidal activity and nitric oxide production.
Interestingly, mice lacking both 
 
α
 
/
 
β
 
 and 
 
γ/δ
 
 T cells were
found to be susceptible to orogastric candidiasis, but not to
acute systemic candidiasis.
 
35
 
As neither 
 
α
 
/
 
β
 
 nor 
 
γ
 
/
 
δ
 
 T cells have any candidacidal or
candiastatic effect per se, clearance of the yeast from the
infected mucosa is probably mediated by phagocytic cells.
Treatment of SCID mice with cyclophosphamide, which
causes severe neutropenia and further impairment of innate
immune mechanisms, enhanced their susceptibility to mucosal
candidiasis
 
36
 
 and impairment of macrophage function by
administration of poly(I-C) increased susceptibility to dis-
seminated candidiasis of endogenous (gastrointestinal tract)
origin.
 
37,38
 
 The resistance of immunocompetent controls to
mucosal candidiasis was not altered by treatment with poly
(I-C) alone, and interference with both macrophage and
neutrophil function was necessary to render these mice sus-
ceptible to the disease.
 
39
 
 In the absence of activation, 
 
Candida
 
killing by phagocytic cells (both neutrophils and macro-
phages) is relatively inefficient, but the candiacidal potential
of both cell types is significantly enhanced by exposure to
Th1-type cytokines, such as IFN-
 
γ
 
 and TNF-
 
α
 
.
Gastrointestinal colonization of athymic
 
34
 
 and SCID
 
40
 
 mice
with 
 
C. albicans
 
 stimulated the expression of inducible nitric
oxide synthase (iNOS) in the gastric and oral mucosa.
Inhibition of NO production in SCID mice enhanced their
susceptibility to orogastric candidiasis, but in athymic mice,
the expression of iNOS was controlled by 
 
γ
 
/
 
δ
 
 T cells
 
34
 
because depletion of these cells not only abrogated the
expression of iNOS in the tongue and stomach but also
increased susceptibility to orogastric candidiasis. In contrast,
immunocompetent mice did not express iNOS in the orogas-
tric mucosa after they were monoassociated with 
 
C. albicans
 
,
and mucosal candidiasis was not exacerbated after treatment
with NOS inhibitors.
 
34
 
 However, there was no direct correla-
tion between nitric oxide production and 
 
Candida
 
 killing.
 
41
 
These authors suggested that nitric oxide was candidastatic
rather than candidacidal, and was associated with or induced
other macrophage candidacidal mechanisms.
Oral candidiasis
There are few models of oral, as distinct from mucosal,
infection. As expected, Candida infection of the oral mucosa
in mice triggers an inflammatory response and stimulates
cellular immunity.42 A comparison of oral infection in BALB/c
and DBA/2 mice, that carry the same MHC haplotype (H-2d),
demonstrated an increase in MAC-1+ cells in both strains, and
a similar recruitment of CD4+ and CD8+ T lymphocytes into
the mucosal tissue.43 The presence of intraepithelial CD4+ T
cells was also five- to sevenfold greater in infected animals
compared to control mice.44 Infection was associated with an
influx of γ/δ T cells, on day 3 in BALB/c mice but on day 5 in
the DBA/2 strain, that correlated with a substantial decrease
in the number of viable organisms recovered from the
mucosal tissue.43
Oral infection resulted in the development of systemic
immunity, demonstrable as Candida-specific DTH responses
in the susceptible DBA/2, but not in the more resistant BALB/
c mice.43 Humoral immune responses could be detected after
infection had resolved45 but levels of serum IgG and salivary
IgA antibodies were higher in BALB/c than in DBA/2 mice.
Mice infected via the oral cavity, but not intravenously, were
protected against a second oral infection (Farah, unpubl.
data). IgM was the predominant immunoglobulin present in
the serum of these mice. IgG1 was present in BALB/c mice
and, to a lesser extent, in CBA/CaH, but only very small
amounts of IgG2 were detected. However, protection could
not be transferred to naive recipients by transfer of either
serum or cells from orally or systemically immunized mice.
Further studies of oral infection in BALB/c and DBA/2
mice confirmed expansion of the γ/δ cell population after oral
infection45 and demonstrated significantly higher Candida-
specific T-cell proliferation in BALB/c mice as compared to
DBA/2 mice. In the resistant BALB/c mice, rapid clearance
of C. albicans from the oral mucosa was associated with an
early increase in levels of IL-4, IL-12 and IFN-γ in cells from
the cervical lymph nodes, whereas in infection-prone DBA/2
mice that cleared the infection more slowly, expression of
message for IL-4 was delayed, and the levels secreted were
lower.45 In BALB/c mice, monoclonal antibody neutralization
of IL-4 increased the fungal burden and delayed clearance of
the yeast. Thus, in contrast to results in systemically infected
mice,46 Il-4 appears to be an important mediator of protection
in oral candidasis.
As in the gastrointestinal models described above,40,47 NO
was detected in the effector phase of the response against oral
infection48 and has been shown to be an important component
of the host response. In mice, concentrations of NO in saliva
increased after infection and saliva from infected mice inhib-
ited the growth of yeast in vitro. In patients with denture
stomatitis, there was an inverse correlation between levels of
NO in saliva and a number of yeasts recovered from the oral
cavity (Clancy, unpubl. data). In mice, neutralization of IL-4
in vivo caused a marked reduction of NO levels in saliva and
in cultures of cervical lymph node cells after stimulation with
C. albicans antigen.48 Conversely, treatment with NG-
monomethyl-L-arginine (MMLA), which inhibits NO syn-
thesis, led to an increase in C. albicans in the oral cavity and
a concomitant abrogation of expression mRNA for IL-4, but
not IFN-γ, in lymphocytes from the draining lymph nodes.
Paradoxically, inhibition of IL-4 production was accompanied
by an increase in IFN-γ production in susceptible DBA/2
mice48 which tends to argue against a strict Th1/Th2 dichot-
omy as a determinant of resistance and susceptibility in oral
candidiasis. However, in a different model, treatment of orally
infected mice with aminoguanidine (AG), that abrogates
production of NO, had no effect on the magnitude or duration
of infection (Farah, unpubl. data).
Cellular immunodeficiency, particularly infection with
HIV, substantially increases the risk of mucosal infections
with C. albicans, and the nude mouse has been used as a
model of oropharyngeal infection. These mice displayed
increased levels of oral colonization compared to euthymic
controls, and developed a chronic infection.7 There was
extensive hyphal penetration of the epithelium, associated
with infiltration of polymorphonuclear leucocytes and the
formation of microabscesses. CBA/CaH mice, that are pre-
disposed to severe tissue pathology,49 developed a greater
fungal burden and more severe lesions after oral infection
than the ‘low pathology’ BALB/c mice. This is consistent
with the regulation of tissue susceptibility by the Carg1 gene.50
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Established infections in nude mice could be cleared by the
adoptive transfer of syngeneic lymphocytes7 and the protec-
tive effect was mediated by the CD4+, but not the CD8+
lymphocyte subset. Recovery was associated with the pres-
ence of IFN-γ and IL-12 in the cervical and submaxillary
lymph nodes of the reconstituted mice.
Initial attempts to confirm the essential role of T cells in
host resistance by antibody depletion of CD4 or CD8 cells
from normal (euthymic) mice were unsuccessful; however,
when mice were given irradiation to the head and neck,
depletion of CD4+, but not CD8+, lymphocytes caused a
prolongation of infection and increased severity of oral
lesions with hyphae penetrating the oral mucosa.51 In the
irradiated mice, recovery from infection was associated with
production of high levels of IL-12 by lymph node cells, but
concentrations of IFN-γ in infected mice were comparable to
those in controls. Either depletion of neutrophils or inactiva-
tion of macrophages/monocytes increased the severity of
infection in BALB/c mice, but had a lesser effect in CBA/
CaH.52 Depletion of both cell populations further increased
infection in BALB/c mice, but dramatically exacerbated the
fungal burden in the CBA/CaH strain. It therefore seems that
phagocytic cells play a more dominant role in the susceptible
CBA/CaH mice than in the resistant strains, although there
was no significant difference in clearance of chronic infec-
tions in nude mice of either strain after reconstitution with
lymphocytes.7
The identity of the mediator(s) that link T cells and
phagocytic effector cells remains elusive, and the relationship
seems quite complex. In general, IL-12 and IFN-γ were the
dominant cytokines produced by lymphocytes from the drain-
ing lymph nodes of recovering animals52 but levels of IL-4
and IL-10 did not show any association with recovery from
oral infection. In contrast, TNF-α was the only cytokine that
was unique to infected oral mucosa.53 Studies of candidiasis
in knockout mice has confused, rather than clarified the issue.
In one study, IFN-γ KO mice showed increased susceptibility
to both gastric and systemic candidiasis,54 whereas another
reported no effect on either form of the disease,55 and a third
found increased mortality of the KO mice although the
increased susceptibility did not correlate with the extent of
organ colonization.56 Ablation of IL-10 increased resistance
against both gastrointestinal57 and systemic58 candidiasis, but
deletion of the gene for IL-4 had no effect.56 Recent studies of
oral candidiasis in IFN-γ, IL-4, IL-10 and iNOS KO mice
have failed to demonstrate any alteration in the severity or
course of the disease (Farah, unpubl. data). In TNF-α KO
mice, there was an early increase in the fungal burden in the
oral cavity, but the duration of the infection was not different
from controls. Infection in IL-12 KO mice, however, was
similar to that in T-cell-deficient nude mice (Fig. 1). The
fungal burden in the oral cavity increased steadily, and
became chronic, persisting undiminished for at least 3 months
(Farah, unpubl.).
The precise role of IL-12 as a mediator of host resistance,
and the anomalous position of IFN-γ, remain to be resolved.
Our failure to identify a particular cytokine or set of cytokines
as a crucial link in the effector pathway against the yeast
may be due to a redundancy among the cytokines that masks
the effect of gene deletion in knockout mice; however, it is
difficult to evaluate the significance of such functional
overlap in vivo. Alternatively, there may exist additional
effector pathways or differences between the experimental
models. Recent studies in nude mice have demonstrated that
bone marrow colony formation in vitro is significantly
depressed in the ‘high pathology’ CBA/CaH mice compared
to BALB/c (Wanasaengsakul, unpubl. data), and reconstitu-
tion of the nude mice with T cells significantly increases the
colony-forming response in infected BALB/c, but not in
infected CBA/CaH mice (Fig. 2). These results suggest that
Figure 1 Fungal colonization of thymus-deficient ‘nude’ and
IL-12 knockout mice compared to mice of the parental strains
after oral infection with 108 Candida albicans yeasts. , IL-12
KO; , nude; , C57/BL6; , BALB/c.
Figure 2 Colony-forming units in the bone marrow of nude
mice reconstituted with lymphocytes from syngeneic normal mice
after oral challenge with 108 C. albicans yeasts. The response of
cells from BALB/c mice is significantly greater than those from
CBA/CaH mice (P < 0.001). , CBA/CaH; , BALB/c.
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one effector pathway may be T-cell-mediated enhancement of
phagocytic cell production by the bone marrow.
Although using the same isolate of yeast, ‘traumatic’ and
‘atraumatic’ modes of infection showed substantial differ-
ences between the experimental models. After oral infection,
DBA/2 mice showed a bimodal pattern of colonization,43 a
feature reproduced by Elahi45 whereas Farah59 demonstrated
only a single peak (Fig. 3). As both studies were carried out
using the same yeast isolate (3630, from the Mycology
Reference Laboratory at the Royal North Shore Hospital), it
seemed probable that the course of oral infection in this
mouse strain was influenced by the actual technique used for
infection. Elahi45 pressed the yeast onto the gums using a
small swab, whereas Farah7 introduced a suspension of yeasts
into the mouth without damaging or traumatizing the oral
mucosa. Thus, in the former case, microtrauma may have
facilitated both deeper penetration of the yeast and the rapid
elicitation of protective cell-mediated immune response.
When inoculation is atraumatic, adhesion of the yeast to the
oral mucosa may be more difficult to establish, and innate
immune mechanisms may be more directly involved and
more effective in eradication of the yeasts.
This observation led us to test the hypothesis that there
was a gradation in host responses from innate to adaptive
immunity that was determined by the severity of the infec-
tious challenge. Nude mice develop chronic infections after
oral challenge with 108 yeasts. However, as the doses used for
infection were progressively decreased, the magnitude of the
fungal burden in the chronically infected mice decreased
proportionally (Fig. 4), until eventually the nude mice were
able to clear the infection completely. Thus, the requirement
for CD4+ T cells for clearance of the infection in these mice
apparently relates to the immunological deficit that permitted
the infection to become established – a situation comparable
to the susceptibility to oropharyngeal candidiasis of HIV/
AIDS patients. It is noteworthy that in neither the human nor
the experimental model is there any systemic dissemination
of the mucosal infection, suggesting that innate immunity
may also play a major role in the response against systemic
disease.
Systemic candidiasis
Considerable insight into the pathogenesis of the systemic
disease has been obtained by comparing inflammatory and
immune responses in inbred strains of mice that exhibit
different patterns of susceptibility to infection with the yeast.
Susceptibility to systemic candidiasis has been evaluated by
gross measures such as mortality, by colony counts in
infected tissues, and by histological evaluation of the severity
of lesions in the tissues.
The most informative was histopathological assessment,
which revealed two distinct patterns of tissue destruction in the
brains of inbred mice of different strains.60 Lesions in mice
with high pathology were characterized by numerous large
abscesses containing yeast and mycelial growth forms within
the necrotic debris, together with an inflammatory infiltrate
consisting of mononuclear and polymorphonuclear leuco-
cytes. Mice with mild lesions (low pathology) showed similar
characteristics, but the abscesses were small and infrequent.
Figure 3 Representation of patterns of colonization that develop
in ‘infection-prone’ DBA/2 mice using different techniques of
infection. Atraumatic infection involves direct inoculation of a
suspension of yeasts into the oral cavity; in the traumatic method,
the pelleted yeast is pressed onto the gums and oral mucosa using
an ear, nose and throat (ENT) swab. , traumatic; , atraumatic.
Figure 4 Oral colonization of nude mice after infection with
differing doses of C. albicans yeasts.
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Mild and severe tissue damage can also be discerned in other
organs, but these patterns do not show a strong correlation
with either mortality or with the fungal burden in infected
tissues.61 The mild and severe patterns of lesion severity are
heritable and controlled by a single co-dominant gene.62 The
variables that determine the expression of mild or severe
tissue damage have not yet been defined but, as the pheno-
types are expressed in nude mice,63 they are probably related
to qualitative or quantitative differences in the effector func-
tions of bone marrow-derived phagocytic cells.
Mortality correlates poorly with tissue damage; however,
mice deficient in the fifth component of complement die after
challenge with substantially lower doses of C. albicans than
complement sufficient mice,64,65 typically from acute fungal
pyelonephritis. An evaluation of the role of C5 in normal and
immune congenic resistant B10.D2 ‘old’ and ‘new’ mice66
demonstrated that an intact complement system contributes to
inhibition of the growth of C. albicans, but the presence or
absence of C5 did not affect the development of specific
immune responses or the ultimate outcome of challenge. The
presence of C5 appears to be crucial in limiting the initial
fungal growth in the kidney67 and, as the candidacidal activity
of phagocytic cells from normal and C5-deficient mice is
equivalent,68 it is clear that the opsonizing and/or chemotactic
properties of C5 are critical factors in the early containment
and elimination of the yeast. However, neither the severity
nor the duration of kidney infection in C5-deficient mice is
influenced by depletion of T cells.59
Although there are many reports of the T-cell-dependence
of host responses against disseminated Candida infection
(reviewed in 8) these have been carried out in one experi-
mental system, and the paradigm that has evolved to explain
susceptibility and resistance to infection has yet to be inde-
pendently confirmed. In brief, this model used various combi-
nations of yeasts (attenuated and virulent), and mouse strains
(DBA/2 and BALB/c), to produce healing infections that
resolved with the development of resistance to re-infection, or
non-healing infections that led to chronic disease and death.
Cytokine production in healing combinations was associated
with the generation of a Th1 cytokine profile by CD4+ spleen
cells in vitro, whereas a Th2 profile developed in lympho-
cytes from animals with chronic disease. Neutralization of
IFN-γ in vivo prevented the development of protective Th1
responses69 whereas neutralization of IL-4 reduced mortality
with a concomitant induction of a Th1 cytokine profile and
development of protective immunity.46
Other models have demonstrated alternative pathways of
host resistance. Neither nude11,12 nor SCID13 mice show any
increased susceptibility to systemic infection, indicating that
cells of the innate immune system are competent to clear the
yeast in the absence of activation by T cells or their products.
It had been thought that the resistance to disseminated candi-
diasis of T-cell-deficient mice might be attributable to non-
specific activation of macrophages known to occur in these
animals;70 however, macrophage activation by treatment with
Bacille Calmette-Guerin (BCG) did not enhance resistance.71
The contrast between the resistance of T-cell-deficient nude
mice to disseminated infection, and their acute susceptibility
to oral infection,7 strongly suggests that the dominant effector
response is different in the two types of infection. Further-
more, mice in which the T-cell receptor δ- and α-chains had
been genetically deleted were highly susceptible to orogastric
candidiasis,35 but remained resistant to disseminated candidia-
sis of endogenous origin and to acute systemic candidiasis
induced by intravenous challenge. The differences in host
responses exhibited by the various models of systemic candi-
diasis have not yet been addressed, and the precise role of T
cells is still incompletely understood.
Mice that are genetically susceptible or resistant to tissue
damage display substantial differences in both early immune
and inflammatory responses, and in the nature and evolution
of immunological memory. BALB/c (H-2d) mice, that
develop mild lesions, show a significantly greater recruitment
of immune/inflammatory cells to the draining lymph node
after subcutaneous challenge with live Candida yeasts than
do CBA/CaH (H-2 k) mice, in which the lesions are more
severe.60 However, these responses do not correlate with the
severity of tissue damage as BALB/k (H-2 k) mice, that
develop only mild lesions, are low responders. In contrast,
both BALB/c and BALB/k mice make strong proliferative
and DTH responses when challenged after recovery from a
primary systemic infection, whereas the response of CBA/CaH
lymphocytes remains low.72 The contrast between the both
primary and secondary immune responses of MHC-identical
CBA/CaH and BALB/k mice suggests that infection in the
genetically tissue-susceptible strain may elicit some form of
regulatory activity that inhibits the development or expression
of Candida-specific T-cell activity.
Although there is an inverse correlation between the mag-
nitude of the cell-mediated immune response and the extent of
tissue destruction in the susceptible and resistant mice, yeast
is cleared from the spleen of the susceptible CBA/CaH strain
more rapidly than from the resistant BALB/c mice.49 A
similar disjunction between immune responses in spleen and
other organs has recently been reported. A Th1-type cytokine
response developed in the kidney after sub-lethal infection,
whereas a Th2 response was seen after lethal challenge.73 The
spleen showed Th2 responses only. Thus, it was considered
that the Th subset response in infected organs, rather than in
the lymphoid tissue, was associated with mortality or survival.
The role of T cells in tissue resistance against disseminated
infection has also been evaluated directly by depletion of
T cells in vivo.14 Overall, depletion of CD4+ cells did not
influence fungal colonization or outcome of infection in
BALB/c or CBA/CaH mice, although there was a significant,
but transient, decrease in the fungal burden in the brain of the
latter strain.
The effect of T-cell depletion on lesion severity was
strikingly different. Depletion of CD4+ cells from BALB/c
mice caused a marked increase in tissue damage associated
with infection. In contrast, depletion of CD4+ cells from
CBA/CaH mice delayed the onset of tissue damage by about
4 days when compared with BALB/c mice.14 After this time,
tissue damage was exacerbated in the same way, and to the
same extent, as in the BALB/c mice. After passive transfer
into infected syngeneic recipients, spleen cells from infected
CBA/CaH mice markedly increased tissue damage when
compared to controls, and also caused a significant increase in
fungal colonization in the brain. A similar transfer in BALB/c
mice increased the number of inflammatory cells in and
around the lesions, but had no effect on the fungal burden in
brain and kidney. The data suggest that systemic infection
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results in the generation of CD4+ T-cell populations that limit
tissue damage and/or enhance healing, but that do not directly
augment clearance of the organism from infected tissues.
The phenotype of these lymphocytes has not yet been
determined; however, there is a parallel between the activities
of these T cells and those of a population of regulatory
CD4+CD25+ T cells that have been demonstrated in mice with
candidiasis.74 This cell population produced IL-4, IL-10 and
TGF-β, required an IL-10-enriched environment for its
generation, and was not present in B7-2- or CD28-deficient
mice which, although capable of efficiently restricting fungal
growth, experienced increased inflammatory pathology.
There is an early abundance of IL-10 in CBA/CaH compared
to BALB/c mice (Wanasaengsakul, unpubl.), and this might
favour the generation of these regulatory cells and the
production of Candida-specific IgG1 and IgG2a antibodies
(Hu, unpubl. data) in CBA/CaH mice, whereas high levels
of IFN-γ and a relative lack of IL-10 would drive antibody
production by BALB/c mice towards a predominantly IgG1
isotype.
Downregulation of cell-mediated immune responses in
CBA/CaH mice correlates with the severe pattern of tissue
damage and the presence of the susceptible allele of the
Carg1 gene in this strain. In addition, CD8+ lymphocytes
from primed CBA/CaH, but not BALB/c, mice can be acti-
vated for anti-self recognition and reactivity75 although the
relevance of this to the specific response against the organism,
or to the general biology of the animal, remains unknown.
Nevertheless, these experiments suggest that the genetic
context in which the immune response evolves influences the
effector function of both T cell subsets.
Conclusion
A key issue in the study of Candida infection is the complex
relationship between innate and adaptive immunity, and the
role played by each in different manifestations of the disease.
Both clinical and experimental data are consistent with a
central role for T cells and cell-mediated immunity in the
host response against oropharyngeal candidiasis, but further
research will be needed to understand the way in which the
presentation of the infectious challenge triggers the transition
from an innate to a specific adaptive immune response.
Understanding the systemic disease remains a challenge,
with formidable cases having been made for a dominant role
of both adaptive and innate immunity. Patterns of cytokine
production may be determined not only by the characteristics
of the yeast used for infection, but also by the genetic makeup
of the host, with both MHC and non-MHC genes clearly
influencing the evolution of the immune response; but how,
or indeed whether, this is reflected in efficiency of clearance
of the yeast, or in the extent of the associated pathology, is a
question that remains to be resolved.
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